Amgen Inc. buy Royal Bank of Canada
Start price
04.02.26
/
50%
€282.50
Target price
04.02.27
€304.45
Performance (%)
9.24%
Price
12.02.26
€308.60
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada shows slight gains of 9.24%. This prediction currently runs until 04.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Amgen Inc. | -1.185% |
| iShares Core DAX® | 1.301% |
| iShares Nasdaq 100 | 0.612% |
| iShares Nikkei 225® | 8.772% |
| iShares S&P 500 | 0.254% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $335.00 to $360.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat